Women's health dialogue
Executive Summary
Participation of women in clinical trials will be discussed at FDA Office of Women's Health meeting April 18. Product safety, consumer education and outreach will also be addressed. The meeting will begin at 10:30 a.m. at the HHS Humphrey Building in Washington D.C